ID   SUP-B24
AC   CVCL_A313
DR   Wikidata; Q54970866
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1434795;
RX   PubMed=8231254;
CC   Population: Caucasian.
CC   Doubling time: ~72 hours (PubMed=1434795).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A317 ! SUP-B31
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1434795;
RA   Neely E.K., Rosenfeld R.G., Illescas A., Smith S.D.;
RT   "Mitogenic effects of human recombinant insulin on B-cell precursor
RT   acute lymphoblastic leukemia cells.";
RL   Leukemia 6:1134-1142(1992).
//
RX   PubMed=8231254;
RA   Zhang L.Q., Downie P.A., Goodell W.R., McCabe N.R., Le Beau M.M.,
RA   Morgan R., Sklar J., Raimondi S.C., Miley D., Goldberg A., Lu M.-M.,
RA   Montag A., Smith S.D.;
RT   "Establishment of cell lines from B-cell precursor acute lymphoblastic
RT   leukemia.";
RL   Leukemia 7:1865-1874(1993).
//